Survival with docetaxel plus capecitabine comparing with vinorelbine plus capecitabine followed by capecitabine maintenance treatment as first-line therapy in patients with advanced breast cancer: A phase III randomized clinical trial

被引：0
|
作者：
Xu, Binghe
Wang, Jiayu
Li, Qing
Zhang, Pin
Yuan, Peng
Ma, Fei
Cai, Ruigang
Fan, Ying
Luo, Yang
Li, Qiao
机构：
[1] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp & Inst, Beijing 100730, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China
[5] Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100730, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1049
引用
收藏
页数：1
相关论文
共 50 条
  • [21] RANDOMIZED CROSS-OVER AIO PHASE III TRIAL COMPARING GEMCITABINE PLUS ERLOTINIB FOLLOWED BY CAPECITABINE VS. CAPECITABINE PLUS ERLOTINIB FOLLOWED BY GEMCITABINE IN ADVANCED PANCREATIC CANCER
    Boeck, S.
    Vehling-Kaiser, U.
    Waldschmidt, D.
    Kettner, E.
    Maerten, A.
    Winkelmann, C.
    Klein, S.
    Kojouharoff, G.
    Jung, A.
    Heinemann, V.
    ANNALS OF ONCOLOGY, 2010, 21 : 233 - 233
  • [22] A Three-Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines
    Campone, Mario
    Dobrovolskaya, Natalya
    Tjulandin, Serjei
    Chen, Shin-Chen
    Fourie, Sameul
    Mefti, Fawzia
    Konstantinova, Maria
    Lefresne, Florence
    Meheust, Nadege
    Jassem, Jacek
    BREAST JOURNAL, 2013, 19 (03): : 240 - 249
  • [23] Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial.
    Guo, Weijian
    Zhu, Xiaodong
    Huang, Mingzhu
    Wang, Yusheng
    Chen, Zhiyu
    Feng, Wanjing
    He, Yifu
    Zhang, Xiaowei
    Liu, Xin
    Wang, Chenchen
    Zhang, Wen
    Ying, Jieer
    Wu, Jun
    Yang, Lei
    Qin, Yanru
    Zhao, Xiaoying
    Li, Wenhua
    Zhang, Zhe
    Qiu, Lixin
    Wang, XiaoFeng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Oral vinorelbine plus capecitabine combination in patients with advanced breast cancer
    Sambiasi, D.
    Spada, M.
    Giampaglia, M.
    Misino, A.
    Calabrese, R.
    Latorre, A.
    Lorusso, V.
    ANNALS OF ONCOLOGY, 2005, 16 : 145 - 145
  • [25] Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer
    Favier, Laure
    Isambert, Nicolas
    Zanetta, Sylvie
    Ferrant, Ernmanuelle
    Mayer, Francoise
    Chauffert, Bruno
    Fumoleau, Pierre
    Garnier, Jerome
    Biville, Fabienne
    Coudert, Bruno
    BREAST, 2008, 17 (01): : 36 - 41
  • [26] Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: Phase III trial results
    O'Shaughnessy, J
    Miles, D
    Vukelja, S
    Moiseyenko, V
    Ayoub, JP
    Cervantes, G
    Fumoleau, P
    Jones, S
    Lui, WY
    Mauriac, L
    Twelves, C
    Van Hazel, G
    Verma, S
    Leonard, R
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (12) : 2812 - 2823
  • [27] Activity and safety of biweekly docetaxel plus capecitabine as first-line treatment for patients with metastatic breast cancer.
    Llorca, C
    Mayordomo, J
    Adrover, E
    Alvarez, I
    Madroñal, C
    Burillo, M
    Sanz, J
    Lorenzo, A
    Palombo, H
    Janariz, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 73S - 73S
  • [28] Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Ghosn, M
    Kattan, J
    Farhat, F
    Younes, F
    Gasmi, J
    ANTICANCER RESEARCH, 2006, 26 (3B) : 2451 - 2456
  • [29] Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in HER2-Positive Metastatic Breast Cancer
    Wardley, Andrew M.
    Pivot, Xavier
    Morales-Vasquez, Flavia
    Zetina, Luis M.
    Dias Gaui, Maria de Fatima
    Reyes, Douglas Otero
    Jassem, Jacek
    Barton, Claire
    Button, Peter
    Hersberger, Veronica
    Torres, Antonio Anton
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) : 976 - 983
  • [30] Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer
    Chua, Daniel T. T.
    Yiu, Harry Ho-Yin
    Seetalarom, Kasan
    Ng, Alice Wan-Ying
    Kurnianda, Johan
    Shotelersuk, Kanjana
    Krishnan, Gopala
    Hong, Ruey-Long
    Yang, Muh-Hwa
    Wang, Cheng-Hsu
    Sze, Wing-Kin
    Ng, Wai-Tong
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (09): : 1225 - 1230
12345